Clinical Trials Logo

Eating Disorder clinical trials

View clinical trials related to Eating Disorder.

Filter by:

NCT ID: NCT06230107 Completed - Eating Disorders Clinical Trials

The Effects of Nutritional Intervention in Participants With Eating Disorders.

Start date: October 18, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the effects of nutritional intervention in eating disorders. Participants underwent an intervention without a control group over 8 weeks. This study aims to provide the maximization of nutritional rehabilitation and support changes in the construction of food autonomy, through a food and nutritional intervention.

NCT ID: NCT05562258 Recruiting - Eating Disorder Clinical Trials

Development and Testing of a Peer-Coaching Model for the Treatment of Eating Disorders

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

This project includes developing and testing a coaching approach during the treatment of eating disorders. It is expected that with the addition of support outside of regular treatment, caregivers will experience improvements in emotional taxation and patients will strengthen skills necessary for recovery. Twelve weeks of coaching will be incorporated into standard treatment. Randomization will occur placing participants into (1) parent coaching + patient educational materials or (2) parent educational materials + patient coaching.

NCT ID: NCT04091477 Completed - Eating Disorder Clinical Trials

Impact of Neuropsychological Alteration of Patients With Eating Disorders

NeuropsyTCA
Start date: October 1, 2019
Phase:
Study type: Observational

Eating disorders are multifactorial disorders currently conceptualized in a biopsychosocial model, but pathophysiology remains relatively unknown, and robust etiological models to guide treatment are therefore lacking. Different endophenotypes and neurocognitive vulnerability factors have been found in eating disorders including decision making abnormalities. The investigators hypothesize that decision making abnormalities are associated with a lower level of functioning and quality of life which could lead to social and interpersonal difficulties. The investigators also hypothesize that these anomalies are associated with a particular clinical profile (more restrictive profile, more hyperactivity, less insight on the disease and desire for care ...).

NCT ID: NCT03948217 Terminated - Anorexia Nervosa Clinical Trials

The Effects of Artificial Lighting on Affective and Core Symptoms of Eating Disorder

METROPOLIS
Start date: May 1, 2018
Phase: N/A
Study type: Interventional

The primary objective of this pilot study is to explore the effect of artificial lighting on affective symptoms, and the secondary aim is to explore the effect of artificial lighting on core symptoms of eating disorders (ED). Several lines of evidence, albeit from hypothesis generation studies, suggest that artificial lighting may have a positive effect on well-being, mental health and affective symptoms in ED. The rationale of this study is to investigate the effects of artificial lighting on affective symptoms and cores symptoms of ED in inpatients undergoing weight restoration/treatment for ED. Study design: Single-blind, controlled, pilot intervention study with circadian light (CL) comparing two CL regimens effects on mood symptoms. Planned number of subjects: 16 patients with a ICD-10 diagnosis of Anorexia Nervosa, that completes exposure to at least three weeks of the two different CL regimens (L1 and L2) in any order.

NCT ID: NCT03934697 Completed - Anorexia Nervosa Clinical Trials

Imaginal Exposure II Study: In-Vivo

In-vivo IE II
Start date: May 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to test if imaginal exposure therapy can decrease symptoms of eating disorders and anxiety.

NCT ID: NCT03921632 Completed - Eating Disorder Clinical Trials

Impact of an Oral Health Intervention

Start date: January 1, 2016
Phase: N/A
Study type: Interventional

This pilot study will assess the effectiveness of an original oral health education program on affecting the behaviors of patients diagnosed with eating disorders.

NCT ID: NCT03911674 Completed - Eating Disorder Clinical Trials

Effects of Oral Stimulation in Preterm Infants

Start date: September 1, 2017
Phase: Phase 3
Study type: Interventional

Preterm infants with gestational age inferior to 34 weeks were included in the study. A prospective experimental group received the oral stimulation protocol and the effects of the intervention were compared with a historical control group that did not receive any oral stimulation intervention. The study hypothesis is that oral stimulation in preterm infants has beneficial effects on the feeding performance, the length of hospitalization and anthropometric variables, including weight at discharge, height at discharge and head circumference at discharge.

NCT ID: NCT03847753 Completed - Stroke Clinical Trials

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

COMO-GMC
Start date: January 1, 2000
Phase:
Study type: Observational [Patient Registry]

Mental disorders have been shown to be associated with a number of general medical conditions (also referred to as somatic or physical conditions). The investigators aim to undertake a comprehensive study of comorbidity among those with treated mental disorders, by using high-quality Danish registers to provide age- and sex-specific pairwise estimates between the ten groups of mental disorders and nine groups of general medical conditions. The investigators will examine the association between all 90 possible pairs of prior mental disorders and later GMC categories using the Danish national registers. Depending on whether individuals are diagnosed with a specific mental disorder, the investigators will estimate the risk of receiving a later diagnosis within a specific GMC category, between the start of follow-up (January 1, 2000) or at the earliest age at which a person might develop the mental disorder, whichever comes later. Follow-up will be terminated at onset of the GMC, death, emigration from Denmark, or December 31, 2016, whichever came first. Additionally for dyslipidemia, follow-up will be ended if a diagnosis of ischemic heart disease was received. A "wash-out" period will be employed in the five years before follow-up started (1995-1999), to identify and exclude prevalent cases from the analysis. Individuals with the GMC of interest before the observation period will be considered prevalent cases and excluded from the analyses (i.e. prevalent cases were "washed-out"). When estimating the risk of a specific GMC, the investigators will consider all individuals to be exposed or unexposed to the each mental disorder depending on whether a diagnosis is received before the end of follow-up. Persons will be considered unexposed to a mental disorder until the date of the first diagnosis, and exposed thereafter.

NCT ID: NCT03796091 Completed - Eating Disorder Clinical Trials

Efficacy Trial of a Dissonance Based Eating Disorder Program

Start date: November 18, 2018
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to investigate whether symptoms of disordered eating change among participants who complete an intervention. Participants will be randomly assigned to one of three intervention conditions and will undergo assessments of symptoms before, after, and 2 months after each intervention. Investigators are evaluating which interventions are most effective in reducing eating disorder symptoms and disorder-related psychological and cardiac risk factors.

NCT ID: NCT03758326 Active, not recruiting - Eating Disorder Clinical Trials

A New Measure of Body Image in Eating Disorders

Start date: March 16, 2018
Phase: N/A
Study type: Interventional

This study aims to compare a new electronic instrument called (here referred to as the 'Body App') with traditional paper and pencil rating scales for assessing how individuals with eating disorders evaluate their body image.